- Home
- ARBB vs PCSA Comparison
ARBB vs PCSA Comparison
Compare ARBB & PCSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBB
- PCSA
- Stock Information
- Founded
- ARBB 1997
- PCSA 2011
- Country
- ARBB Singapore
- PCSA United States
- Employees
- ARBB N/A
- PCSA N/A
- Industry
- ARBB EDP Services
- PCSA Biotechnology: Pharmaceutical Preparations
- Sector
- ARBB Technology
- PCSA Health Care
- Exchange
- ARBB Nasdaq
- PCSA Nasdaq
- Market Cap
- ARBB 13.3M
- PCSA 12.0M
- IPO Year
- ARBB 2023
- PCSA N/A
- Fundamental
- Price
- ARBB $5.64
- PCSA $0.31
- Analyst Decision
- ARBB Strong Buy
- PCSA Strong Buy
- Analyst Count
- ARBB 1
- PCSA 1
- Target Price
- ARBB $20.00
- PCSA $1.00
- AVG Volume (30 Days)
- ARBB 218.7K
- PCSA 5.0M
- Earning Date
- ARBB 11-03-2025
- PCSA 11-06-2025
- Dividend Yield
- ARBB N/A
- PCSA N/A
- EPS Growth
- ARBB N/A
- PCSA N/A
- EPS
- ARBB N/A
- PCSA N/A
- Revenue
- ARBB $46,842,655.00
- PCSA N/A
- Revenue This Year
- ARBB N/A
- PCSA N/A
- Revenue Next Year
- ARBB $24.79
- PCSA N/A
- P/E Ratio
- ARBB N/A
- PCSA N/A
- Revenue Growth
- ARBB 239.12
- PCSA N/A
- 52 Week Low
- ARBB $3.92
- PCSA $0.15
- 52 Week High
- ARBB $18.60
- PCSA $1.50
- Technical
- Relative Strength Index (RSI)
- ARBB 46.42
- PCSA 50.50
- Support Level
- ARBB $5.41
- PCSA $0.28
- Resistance Level
- ARBB $6.00
- PCSA $0.35
- Average True Range (ATR)
- ARBB 0.60
- PCSA 0.05
- MACD
- ARBB -0.02
- PCSA -0.01
- Stochastic Oscillator
- ARBB 18.15
- PCSA 31.04
About ARBB ARB IOT Group Limited
ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things Solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.
About PCSA Processa Pharmaceuticals Inc.
Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).